458 related articles for article (PubMed ID: 23821689)
21. [Management of direct action oral anticoagulants in the peri-operative period and invasive techniques].
Llau JV; Ferrandis R; Castillo J; de Andrés J; Gomar C; Gómez-Luque A; Hidalgo F; Torres LM;
Rev Esp Anestesiol Reanim; 2012; 59(6):321-30. PubMed ID: 22633209
[TBL] [Abstract][Full Text] [Related]
22. Emergency surgery and trauma in patients treated with the new oral anticoagulants: dabigatran, rivaroxaban, and apixaban.
Moorman ML; Nash JE; Stabi KL
J Trauma Acute Care Surg; 2014 Sep; 77(3):486-94; quiz 486-94. PubMed ID: 25159255
[No Abstract] [Full Text] [Related]
23. [Clinical pharmacological aspects of new oral anticoagulants].
Haschke M
Ther Umsch; 2012 Nov; 69(11):657-60. PubMed ID: 23117669
[TBL] [Abstract][Full Text] [Related]
24. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
Lip GY; Larsen TB; Skjøth F; Rasmussen LH
J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
[TBL] [Abstract][Full Text] [Related]
25. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.
Steed MB; Swanson MT
Oral Maxillofac Surg Clin North Am; 2016 Nov; 28(4):515-521. PubMed ID: 27624772
[TBL] [Abstract][Full Text] [Related]
26. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
[TBL] [Abstract][Full Text] [Related]
27. A new era of oral anticoagulation in atrial fibrillation: implications in clinical practice.
Kasmeridis C; Lip GY; Apostolakis S
Hosp Pract (1995); 2013 Feb; 41(1):61-70. PubMed ID: 23466968
[TBL] [Abstract][Full Text] [Related]
28. Bleeding and antidotes in new oral anticoagulants.
Majeed A; Schulman S
Best Pract Res Clin Haematol; 2013 Jun; 26(2):191-202. PubMed ID: 23953907
[TBL] [Abstract][Full Text] [Related]
29. Approach to the new oral anticoagulants in family practice: part 1: comparing the options.
Douketis J; Bell AD; Eikelboom J; Liew A
Can Fam Physician; 2014 Nov; 60(11):989-95. PubMed ID: 25392438
[TBL] [Abstract][Full Text] [Related]
30. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.
Banerjee A; Lane DA; Torp-Pedersen C; Lip GY
Thromb Haemost; 2012 Mar; 107(3):584-9. PubMed ID: 22186961
[TBL] [Abstract][Full Text] [Related]
31. Drug and dietary interactions of the new and emerging oral anticoagulants.
Walenga JM; Adiguzel C
Int J Clin Pract; 2010 Jun; 64(7):956-67. PubMed ID: 20584229
[TBL] [Abstract][Full Text] [Related]
32. Acute management of bleeding in patients on novel oral anticoagulants.
Siegal DM; Crowther MA
Eur Heart J; 2013 Feb; 34(7):489-498b. PubMed ID: 23220847
[TBL] [Abstract][Full Text] [Related]
33. Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.
Alotaibi G; Alsaleh K; Wu C; Mcmurtry MS
Int Angiol; 2014 Aug; 33(4):301-8. PubMed ID: 25056161
[TBL] [Abstract][Full Text] [Related]
34. Novel oral anticoagulants for thromboprophylaxis after orthopaedic surgery.
Quinlan DJ; Eriksson BI
Best Pract Res Clin Haematol; 2013 Jun; 26(2):171-82. PubMed ID: 23953905
[TBL] [Abstract][Full Text] [Related]
35. {blacktriangledown} Apixaban and {blacktriangledown} rivaroxaban for stroke prevention in AF.
Drug Ther Bull; 2014 Jan; 52(1):6-9. PubMed ID: 24401533
[TBL] [Abstract][Full Text] [Related]
36. Review of recently approved alternatives to anticoagulation with warfarin for emergency clinicians.
Brem E; Koyfman A; Foran M
J Emerg Med; 2013 Jul; 45(1):143-9. PubMed ID: 23375217
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacodynamic and pharmacokinetic characteristics. Mechanism of action of the new oral anticoagulants].
Roldán Schilling V; Vicente García V
Med Clin (Barc); 2012 Oct; 139 Suppl 2():10-2. PubMed ID: 23498066
[TBL] [Abstract][Full Text] [Related]
38. [Bleeding complications under oral anticoagulation].
Beyer-Westendorf J
Dtsch Med Wochenschr; 2014 Dec; 139(49):2491-3. PubMed ID: 25376450
[No Abstract] [Full Text] [Related]
39. Recommendations for the emergency management of complications associated with the new direct oral anticoagulants (DOACs), apixaban, dabigatran and rivaroxaban.
Steiner T; Böhm M; Dichgans M; Diener HC; Ell C; Endres M; Epple C; Grond M; Laufs U; Nickenig G; Riess H; Röther J; Schellinger PD; Spannagl M; Veltkamp R
Clin Res Cardiol; 2013 Jun; 102(6):399-412. PubMed ID: 23669868
[TBL] [Abstract][Full Text] [Related]
40. [New oral anticoagulant agents: the quandary of anticoagulation in the elderly].
Páramo JA
Med Clin (Barc); 2013 Oct; 141(8):346-8. PubMed ID: 23831406
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
